Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post S&P 500 Rises from Bearish to Neutral, But Will It Last? April 27, 2025 Next Post S&P 500 Rises from Bearish to Neutral, But Will It Last? April 28, 2025 Related Posts Feedback of U.S. Department of Defense Award Funding May 19, 2025 CEO Appointment May 19, 2025 WCN Raises A$14.4M at an Average 29% Premium to Market Close May 19, 2025